{"id":785,"date":"2024-03-26T00:27:51","date_gmt":"2024-03-26T07:27:51","guid":{"rendered":"https:\/\/cloudbreakpharma.com\/?page_id=785"},"modified":"2026-03-19T16:01:59","modified_gmt":"2026-03-19T23:01:59","slug":"cbt-199","status":"publish","type":"page","link":"https:\/\/cloudbreakpharma.com\/zh_hk\/pipeline\/cbt-199\/","title":{"rendered":"CBT-199"},"content":{"rendered":"<div data-elementor-type=\"wp-page\" data-elementor-id=\"785\" class=\"elementor elementor-785\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-894d47f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"894d47f\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t\t<div class=\"elementor-background-overlay\"><\/div>\n\t\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-80af24c\" data-id=\"80af24c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-d5988fb elementor-widget elementor-widget-heading\" data-id=\"d5988fb\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">CBT-199<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-19a516f elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"19a516f\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-e0791e6\" data-id=\"e0791e6\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0dac847 elementor-widget elementor-widget-heading\" data-id=\"0dac847\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Presbyopia<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7c60626 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7c60626\" data-element_type=\"section\" data-e-type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-b5e4e44\" data-id=\"b5e4e44\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-1b8de52 elementor-widget elementor-widget-text-editor\" data-id=\"1b8de52\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>CBT-199 is being developed for the treatment of presbyopia, a condition caused by an age-related process. During aging, the lens in the eye gradually becomes thicker and loses flexibility. With less elasticity, there is a loss in the ability of the eye to focus on nearby objects. CBT-199 is a new formulation invented by Cloudbreak, designed to constrict the pupil allowing for improved focus up close.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>CBT-199 Presbyopia CBT-199 is being developed for the treatment of presbyopia, a condition caused by an age-related process. During aging, the lens in the eye gradually becomes thicker and loses flexibility. With less elasticity, there is a loss in the ability of the eye to focus on nearby objects. CBT-199 is a new formulation invented [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":0,"parent":48,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-785","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CBT-199 - Cloudbreak Pharma, Inc.<\/title>\n<meta name=\"description\" content=\"Learn more about CBT-199, a clinical trial for presbyopia eye drops and what happens during presbyopia progression\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cloudbreakpharma.com\/zh_hk\/pipeline\/cbt-199\/\" \/>\n<meta property=\"og:locale\" content=\"zh_HK\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CBT-199 - Cloudbreak Pharma, Inc.\" \/>\n<meta property=\"og:description\" content=\"Learn more about CBT-199, a clinical trial for presbyopia eye drops and what happens during presbyopia progression\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cloudbreakpharma.com\/zh_hk\/pipeline\/cbt-199\/\" \/>\n<meta property=\"og:site_name\" content=\"Cloudbreak Pharma, Inc.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-03-19T23:01:59+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u9810\u8a08\u95b1\u8b80\u6642\u9593\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 \u5206\u9418\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-199\\\/\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-199\\\/\",\"name\":\"CBT-199 - Cloudbreak Pharma, Inc.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#website\"},\"datePublished\":\"2024-03-26T07:27:51+00:00\",\"dateModified\":\"2026-03-19T23:01:59+00:00\",\"description\":\"Learn more about CBT-199, a clinical trial for presbyopia eye drops and what happens during presbyopia progression\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-199\\\/#breadcrumb\"},\"inLanguage\":\"zh-HK\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-199\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/cbt-199\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pipeline\",\"item\":\"https:\\\/\\\/cloudbreakpharma.com\\\/pipeline\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"CBT-199\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\",\"name\":\"Cloudbreak Pharma, Inc.\",\"description\":\"Seeing Life Better Through Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cloudbreakpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-HK\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#organization\",\"name\":\"Cloudbreak Pharma, Inc.\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-HK\",\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/cloudbreak-logo.svg\",\"contentUrl\":\"https:\\\/\\\/cloudbreakpharma.com\\\/wp-content\\\/uploads\\\/2022\\\/08\\\/cloudbreak-logo.svg\",\"width\":824,\"height\":199,\"caption\":\"Cloudbreak Pharma, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/cloudbreakpharma.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CBT-199 - Cloudbreak Pharma, Inc.","description":"Learn more about CBT-199, a clinical trial for presbyopia eye drops and what happens during presbyopia progression","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cloudbreakpharma.com\/zh_hk\/pipeline\/cbt-199\/","og_locale":"zh_HK","og_type":"article","og_title":"CBT-199 - Cloudbreak Pharma, Inc.","og_description":"Learn more about CBT-199, a clinical trial for presbyopia eye drops and what happens during presbyopia progression","og_url":"https:\/\/cloudbreakpharma.com\/zh_hk\/pipeline\/cbt-199\/","og_site_name":"Cloudbreak Pharma, Inc.","article_modified_time":"2026-03-19T23:01:59+00:00","twitter_card":"summary_large_image","twitter_misc":{"\u9810\u8a08\u95b1\u8b80\u6642\u9593":"1 \u5206\u9418"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-199\/","url":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-199\/","name":"CBT-199 - Cloudbreak Pharma, Inc.","isPartOf":{"@id":"https:\/\/cloudbreakpharma.com\/#website"},"datePublished":"2024-03-26T07:27:51+00:00","dateModified":"2026-03-19T23:01:59+00:00","description":"Learn more about CBT-199, a clinical trial for presbyopia eye drops and what happens during presbyopia progression","breadcrumb":{"@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-199\/#breadcrumb"},"inLanguage":"zh-HK","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cloudbreakpharma.com\/pipeline\/cbt-199\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/cloudbreakpharma.com\/pipeline\/cbt-199\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cloudbreakpharma.com\/"},{"@type":"ListItem","position":2,"name":"Pipeline","item":"https:\/\/cloudbreakpharma.com\/pipeline\/"},{"@type":"ListItem","position":3,"name":"CBT-199"}]},{"@type":"WebSite","@id":"https:\/\/cloudbreakpharma.com\/#website","url":"https:\/\/cloudbreakpharma.com\/","name":"Cloudbreak Pharma, Inc.","description":"\u91ab\u85e5\u4f7f\u6211\u5011\u80fd\u66f4\u597d\u7684\u8996\u89ba\u4eab\u53d7\u751f\u6d3b","publisher":{"@id":"https:\/\/cloudbreakpharma.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cloudbreakpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-HK"},{"@type":"Organization","@id":"https:\/\/cloudbreakpharma.com\/#organization","name":"Cloudbreak Pharma, Inc.","url":"https:\/\/cloudbreakpharma.com\/","logo":{"@type":"ImageObject","inLanguage":"zh-HK","@id":"https:\/\/cloudbreakpharma.com\/#\/schema\/logo\/image\/","url":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2022\/08\/cloudbreak-logo.svg","contentUrl":"https:\/\/cloudbreakpharma.com\/wp-content\/uploads\/2022\/08\/cloudbreak-logo.svg","width":824,"height":199,"caption":"Cloudbreak Pharma, Inc."},"image":{"@id":"https:\/\/cloudbreakpharma.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/785","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/comments?post=785"}],"version-history":[{"count":0,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/785\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/pages\/48"}],"wp:attachment":[{"href":"https:\/\/cloudbreakpharma.com\/zh_hk\/wp-json\/wp\/v2\/media?parent=785"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}